Please do not close or refresh this window...
Thursday, May 6, 2021 at 5:30 PM to 8:00 PM CDT
2525 West End Ave, Nashville, TN, 37203, United States
Access code applied successfully. Remove
Invalid access code. Try again
Fleming's, 2525 West End Ave, Nashville, TN, 37203, United States.
Please join us for a discussion on
Enhertu
On behalf of Daiichi Sankyo, Inc. and AstraZeneca, we cordially invite you to join us for an informative, expert-led discussion.
This program will cover:
? An FDA approved therapy for adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prior trastuzumab-based regimen
? Key efficacy and safety results from the Phase 2 clinical trial, DESTINY-Gastric01
? Preparation, dosage, and administration of ENHERTU
? Counseling considerations for patients who are being treated with ENHERTU
Program Details:
Date:
May 6, 2021
6:00 PM – 8:00 PM Central Daylight Time
Speaker:
Kerry Parsons
Location:
Fleming's Prime Steakhouse and Wine Bar
2525 West End Avenue
Nashville, TN 37203
http://middletennessee.vc.ons.org
This event is currently unable to accept new registrations
Please enter below, the secure invite code provided to you by the event organizer in order to proceed...
(Please use a genuine email address. It will be used to validate your request)